Haleon plc (NYSE:HLN) Shares Acquired by SRS Capital Advisors Inc.

SRS Capital Advisors Inc. increased its stake in shares of Haleon plc (NYSE:HLN) by 456.4% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 5,458 shares of the company’s stock after buying an additional 4,477 shares during the quarter. SRS Capital Advisors Inc.’s holdings in Haleon were worth $45,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. Natixis Advisors L.P. lifted its holdings in shares of Haleon by 13.8% in the 4th quarter. Natixis Advisors L.P. now owns 546,494 shares of the company’s stock worth $4,497,000 after acquiring an additional 66,371 shares during the last quarter. Heritage Wealth Management LLC purchased a new position in Haleon in the fourth quarter worth approximately $793,000. First Trust Direct Indexing L.P. grew its stake in shares of Haleon by 66.9% during the fourth quarter. First Trust Direct Indexing L.P. now owns 27,319 shares of the company’s stock worth $225,000 after purchasing an additional 10,947 shares in the last quarter. Hexagon Capital Partners LLC increased its holdings in shares of Haleon by 107.3% in the 4th quarter. Hexagon Capital Partners LLC now owns 4,236 shares of the company’s stock valued at $35,000 after acquiring an additional 2,193 shares during the last quarter. Finally, WealthTrust Axiom LLC raised its holdings in Haleon by 9.5% during the fourth quarter. WealthTrust Axiom LLC now owns 55,188 shares of the company’s stock worth $454,000 after purchasing an additional 4,796 shares in the last quarter. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Stock Performance

Shares of Haleon stock opened at $8.30 on Friday. The firm’s fifty day simple moving average is $8.33 and its 200-day simple moving average is $8.29. Haleon plc has a 12 month low of $7.70 and a 12 month high of $8.98. The stock has a market capitalization of $37.90 billion, a price-to-earnings ratio of 27.67, a PEG ratio of 2.17 and a beta of 0.28. The company has a debt-to-equity ratio of 0.53, a current ratio of 1.04 and a quick ratio of 0.73.

Haleon Dividend Announcement

The firm also recently announced a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be issued a $0.1064 dividend. The ex-dividend date is Thursday, March 14th. This represents a dividend yield of 1.8%. Haleon’s payout ratio is 70.00%.

Analysts Set New Price Targets

HLN has been the topic of several research analyst reports. Argus reiterated a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. HSBC started coverage on Haleon in a research report on Wednesday, April 17th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.